Premium
Cryotherapy for retinopathy of prematurity
Author(s) -
Flage Tor
Publication year - 1993
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.1993.tb04157.x
Subject(s) - cryotherapy , retinopathy of prematurity , medicine , blindness , ophthalmology , childhood blindness , disease , pediatrics , surgery , optometry , pregnancy , gestational age , biology , genetics
Abstract. Retinopathy of prematurity (ROP) is a leading cause of severe visual impairment and blindness in infancy. Transscleral cryotherapy has been shown to be effective in arresting the progression of ROP into the sightthreatening fibrovascular stages of the disease. It is currently recommended that all eyes reaching ‘threshold’ ROP should be treated. If both eyes of an infant reach ‘threshold’, both eyes should be treated. For centers that handle a limited number of infants with ROP it is suggested that the cryotherapy should be done under general anesthesia.